Description: The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Description: Wondering if Cooper Companies stock is a hidden bargain or too expensive in today’s market? Let’s break down what’s really happening beneath the surface. Shares have climbed 6.5% over the past week and 3.3% in the last month, but are still down 16.2% year-to-date and 25.8% over the past year. This signals shifting sentiment and ongoing uncertainty. There have been no headline-making events in recent weeks. However, recent news has focused on changing industry dynamics and evolving investor...

Description: A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a further adjustment” in the near term, sparking a significant market rally. Following his remarks, the probability of the central bank cutting rates at its December meeting jumped from 39% to over 73%, according to the CME FedWatch tool. This positive sentiment provided relief to

Description: Cooper's Lack of Strategic Focus, Misaligned Incentives, and Inadequate Board Oversight Have Led to Meaningful Underperformance Current Corporate Structure Obscures Value of Both CooperVision and CooperSurgical; Refocus as a Pure Play Vision Care Company Under a Refreshed Board May Lead to More Than a Doubling of Cooper's Stock Price Urges Cooper's Board to Appoint Browning West’s Highly Skilled Director Candidates Who Will Improve the Company’s Operating Plans Including Capital Allocation, Over

Description: While Cooper Companies has underperformed relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Description: Exploring Jana Partners (Trades, Portfolio)' Latest 13F Filing and Investment Strategy

Description: Cooper Companies (COO) stock has experienced some ups and downs lately, with shares dipping slightly by 1% on the most recent trading day. Over the past month, however, the stock has managed to edge up by about 1%. See our latest analysis for Cooper Companies. After a volatile stretch, Cooper Companies' share price currently sits at $71.75, well below where it started the year. This reflects a year-to-date share price return of -20.86%. While recent momentum has been tepid, with small...

Description: Aytu BioPharma (AYTU) delivered earnings and revenue surprises of -33.33% and +10.05%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Description: Nike upgraded, Dollar Tree downgraded: Wall Street's top analyst calls

Description: Pre-Market Stock Futures: The stock futures are trading lower on Thursday, following another incredible day for the Dow Jones Industrials, while the rotation out of the NASDAQ and into technology is still gaining traction. The DJIA posted a record all-time high, closing at 48,254, up another 327 points or 0.68%. The S&P 500 just barely ... Here Are Thursday’s Top Wall Street Analyst Research Calls: AbbVie, AppLovin, Autozone, Booking Holdings, CoreWeave, DoorDash, and More

Description: With its stock down 3.7% over the past week, it is easy to disregard Cooper Companies (NASDAQ:COO). We, however decided...

Description: SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results on Thursday, December 4, 2025, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 2700541. A simultaneous audio webcast and su

Description: The Cooper Companies is expected to release its fourth-quarter earnings by early December, and analysts anticipate mid-single-digit growth in earnings.

Description: If you are eyeing Cooper Companies and wondering whether now is the time to jump in or sit tight, you are definitely not alone. The stock has taken investors on quite a ride recently, with gains of 5.3% over the last week and an impressive 10.0% return over the past month. Yet, zoom out and the picture changes. Year-to-date, the stock is down 17.3%, and over the past year, it is off by a notable 29.1%. Even its five-year return stands at -13.3%, reminding us that the path has not been smooth...

Description: Companies in The News Are: SMMT, CLF, LHX, COO

Description: 🔎 A widespread outage linked to Amazon's (AMZN) Amazon Web Services hit many companies early Monday. Coinbase (COIN) and Robinhood (HOOD) were among those whose services were affected. Many services were restored as Amazon worked to address the issue.

Description: Health care stocks rose late Monday afternoon, with the NYSE Health Care Index and the Health Care S

Description: Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.9% and the Health Car

Description: Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 3.1% in the morning session after reports revealed an activist investor, Jana Partners, took a stake in competitor Cooper Companies and was pushing for a potential merger of Cooper's contact-lens business with Bausch + Lomb.

Description: News of the day for Oct. 20, 2025

Description: Shares of Cooper Cos. rose Monday following a report that said an activist investor planned to drive changes at the struggling medical device maker. Activist investor Jana Partners has built a stake in Cooper and plans to push for strategic alternatives, The Wall Street Journal reported, citing people familiar with the matter. Jana may seek a deal to combine Cooper’s contact-lens segment with competitor Bausch + Lomb the report said.

Description: Activist investor Jana Partners has built a stake in Cooper Cos. and plans to push for strategic alternatives, including a potential deal to combine its contact-lens unit with rival Bausch + Lomb according to people familiar with the matter. Jana also plans to push Cooper to make other changes that could help lift shares, including through improving capital allocation and returns, the people said. The global medical-device manufacturer makes contact lenses and vision-care products through its CooperVision segment and provides products and services for women’s health and fertility through CooperSurgical.

Description: Cooper (COO) is under pressure from activist investor Jana Partners, which has built a stake in the

Description: Bausch + Lomb is seen as a potential buyer for the contact-lens unit and the CEO said he would be interested.